AzurRx BioPharma Announces Positive Topline Data For Phase 2 MS1819 Combination Therapy Trial in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency (EPI)

NEXT STORY
MediPharm Labs Receives Export Authorization to Ship Medical Cannabis to Brazil
PREV STORY
Sharps Compliance Reports Fiscal 2021 Fourth Quarter Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cellectar Biosciences Reports First Quarter 2017 Financial and Corporate Performance

MADISON, Wis., May 11, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), ...

author_avatar
NASDAQ Market News

Capital Digestive Care Welcomes Two New Healthcare Professionals

Chevy Chase, MD, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Capital Digestive Care has tapped ...

author_avatar
NASDAQ Market News

Zai Lab Announces Financial Results and Corporate Progress for the Six Months ended June 30, 2018

SHANGHAI, China, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Zai Lab Limited (“Zai Lab” or ...

author_avatar
NASDAQ Market News